Genome-wide association studies of COVID-19 vaccine seroconversion and breakthrough outcomes in UK Biobank by Alcalde-Herraiz, M, Català, M, Prats-Uribe, A, Paredes, R, Xie, J, Prieto-Alhambra, D

Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomes by Alcalde-Herraiz, M, Xie, J, Newby, D, Prats, C, Gill, D, Gordillo-Marañón, M, Prieto-Alhambra, D, Català, M, Prats-Uribe, A

Modifiable lifestyle factors and the risk of post-COVID-19 multisystem sequelae, hospitalization, and death by Wang, Y, Su, B, Alcalde-Herraiz, M, Barclay, NL, Tian, Y, Li, C, Wareham, NJ, Paredes, R, Xie, J, Prieto-Alhambra, D

Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes by Xie, J, Mothe, B, Alcalde Herraiz, M, Li, C, Xu, Y, Jödicke, AM, Gao, Y, Wang, Y, Feng, S, Wei, J, Chen, Z, Hong, S, Wu, Y, Su, B, Zheng, X, Cohet, C, Ali, R, Wareham, N, Prieto Alhambra, D